Melanoma, Cutaneous
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) (NCT05169957) | University of Michigan Rogel Cancer Center | 2022-08-09 |
Track Melanoma, Cutaneous automatically
Every clearance here is in the API, with alerts when new ones post.